Smoking, smoking cessation, and risk of cardiovascular disease

Current Treatment Options in Cardiovascular Medicine

Volumn 8, Issue 4, 2006, Pages 276-281

  Wilson, Peter W F ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMOCRIPTINE; CANNABINOID RECEPTOR; CLONIDINE; DOFETILIDE; ENDOCANNABINOID; MONOAMINE OXIDASE INHIBITOR; NICOTINE; NICOTINE GUM; NICOTINE PATCH; NORTRIPTYLINE; RIMONABANT;

ATHEROSCLEROSIS; BEHAVIOR MODIFICATION; BEHAVIOR THERAPY; BRONCHOSPASM; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; CONSTIPATION; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DIZZINESS; DROWSINESS; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG COST; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; DRUG ERUPTION; ERYTHEMA; FATIGUE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART ARRHYTHMIA; HEART INFARCTION; HEART PALPITATION; HUMAN; HYPERTENSION; IMPOTENCE; INSOMNIA; LIVER TOXICITY; MENTAL DISEASE; MIGRAINE; MOUTH PAIN; MUSCLE WEAKNESS; NICOTINE REPLACEMENT THERAPY; ORTHOSTATIC HYPOTENSION; PATIENT COUNSELING; PHARMACOGENOMICS; PRIMARY PREVENTION; QT PROLONGATION; REVIEW; RISK ASSESSMENT; SECONDARY PREVENTION; SEDATION; SEX DIFFERENCE; SKIN EDEMA; SLEEP DISORDER; SMOKING CESSATION; SMOKING HABIT; TACHYCARDIA; THROAT IRRITATION; THROMBOSIS; WITHDRAWAL SYNDROME; XEROSTOMIA;

EID: 33746114559     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-006-0048-0     Document Type: Review

References (42)

1. Pierce JP, Fiore MC, Novotny TE, et al.: Trends in cigarette smoking in the United States. Projections to the year 2000. JAMA 1989, 261:61-65.
2. The worldwide smoking epidemic. Tobacco trade, use, and control. Council on Scientific Affairs [no authors listed]. JAMA 1990, 263:3312-3318.
3. Doll R, Peto R: Mortality in relation to smoking: twenty years observation of male British doctors. BMJ 1976, 2:1525-1536.
4. Cupples LA, D'Agostino RB: The Framingham Study. An Epidemiological Investigation of Cardiovascular Disease. Section 34: Some Risk Factors Related to the Annual Incidence of Cardiovascular Disease and Death Using Pooled Repeated Biennial Measurements: Framingham Heart Study, 30-year Follow-up, edn 1. Springfield, VA: US Department of Commerce; 1987.
5. Gyntelberg F, Lauridsen L, Beck Pedersen P, Schubell K: Smoking and risk of myocardial infarction in Copenhagen men aged 40-59 with special reference to cheroot smoking. Lancet 1981, 1:987-989.
6. Castelli WP, Garrison RJ, Dawber TR, et al.: The filter cigarette and coronary heart disease: the Framingham Study. Lancet 1981, 2:109-113.
7. Palmer JR, Rosenberg L, Shapiro S: "Low yield" cigarettes and the risk of nonfatal myocardial infarction in women. N Engl J Med 1989, 320:1569-1573.
8. Doll R: Smoking and death rates. JAMA 1984, 251:2854-2857.
9. Herling S, Kozlowski LT: The importance of direct questions about inhalation and daily intake in the evaluation of pipe and cigar smokers. Prev Med 1988, 17:73-78.
10. Fielding JE, Phenow KJ: Health effects of involuntary smoking. N Engl J Med 1988, 319:1452-1460.
11. Beaglehole R: Does passive smoking cause heart disease? BMJ 1990, 301:1343-1344.
12. McGill HC Jr: Potential mechanisms for the augmentation of atherosclerosis and atherosclerotic disease by cigarette smoking. Prev Med 1979, 8:390-403.
13. Craig WY, Palomaki GE, Haddow JE: Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 1989, 298:784-788.
14. Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet 1987, 2:986-988.
15. Jick H, Porter J, Morrison AS: Relation between smoking and age of natural menopause: report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Lancet 1977, 1:1354-1355.
16. Marti B, Abelin T, Minder CE, Vader JP: Smoking, alcohol consumption, and endurance capacity: an analysis of 6,500 19-year old conscripts and 4,100 joggers. Prev Med 1988, 17:79-92.
17. Thaw KT, Tazuke S, Barrett-Connor EL: Cigarette smoking and levels of adrenal androgens in postmenopausal women. N Engl J Med 1988, 318:1705-1709.
18. Barrett-Connor E, Khaw KT: Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. Circulation 1988, 78:539-545.
19. Rigotti NA: Cigarette smoking and body weight. N Engl J Med 1989, 320:931-933.
20. Kannel WB, D'Agostino RB, Belanger AJ: Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. Am Heart J 1987, 113:1006-1010.
21. Keaney JF Jr, Larson MG, Vasan RS, et al.: Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham study. Arterioscler Thromb Vasc Biol 2003, 23:434-439.
22. Visser M, Bouter LM, McQuillan GM, et al.: Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999, 282:2131-2135.
23. Hecht SS, Murphy SE, Carmella SG, et al.: Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettes. Cancer Epidemiol Biomarkers Prev 2005, 14:693-698.
24. Benowitz NL, Herrera B, Jacob P III: Mentholated cigarette smoking inhibits nicotine metabolism. J Pharmacol Exp Ther 2004, 310:1208-1215.
25. Huang S, Cook DG, Hinks LJ, et al.: CYP2A6, MAOA, DBH, DRD4, and 5HT2A genotypes, smoking behaviour and cotinine levels in 1518 UK adolescents. Pharmacogenet Genomics 2005, 15:839-850.
26. Joseph AM, Bliss RL, Zhao F, Lando H: Predictors of smoking reduction without formal intervention. Nicotine Tob Res 2005, 7:277-282.
27. Hilleman DE, Mohiuddin SM, Packard KA: Comparison of conservative and aggressive smoking cessation treatment strategies following coronary artery bypass graft surgery. Chest 2004, 125:435-438.
28. Sivarajan Froelicher ES, Miller NH, Christopherson DJ, et al.: High rates of sustained smoking cessation in women hospitalized with cardiovascular disease: the Women's Initiative for Nonsmoking (WINS). Circulation 2004, 109:587-593.
29. Croghan IT, Schroeder DR, Hays JT, et al.: Nicotine dependence treatment: perceived health status improvement with 1-year continuous smoking abstinence. Eur J Public Health 2005, 15:251-255.
30. Ockene JK, Kuller LH, Svendsen KH, Meilahn E: The relationship of smoking cessation to coronary heart disease and lung cancer in the Multiple Risk Factor Intervention Trial (MRFIT). Am J Public Health 1990, 80:954-958.
31. Jajich CL, Ostfeld AM, Freeman DH: Smoking and coronary heart disease mortality in the elderly. JAMA 1984, 252:2831-2834.
32. LaCroix AZ, Lang J, Scherr P, et al.: Smoking and mortality among older men and women in three communities. N Engl J Med 1991, 324:1619-1625.
33. An LC, Zhu SH, Nelson DB, et al.: Benefits of telephone care over primary care for smoking cessation: a randomized trial. Arch Intern Med 2006, 166:536-542.
34. Fu SS, Sherman SE, Yano EM, et al.: Ethnic disparities in the use of nicotine replacement therapy for smoking cessation in an equal access health care system. Am J Health Promot 2005, 20:108-116.
35. Frishman WH, Mitta W, Kupersmith A, Ky T: Nicotine and non-nicotine smoking cessation pharmacotherapies. Cardiol Rev 2006, 14:57-73.
36. Perkins KA, Doyle T, Ciccocioppo M, et al.: Sex differences in the influence of nicotine dose instructions on the reinforcing and self-reported rewarding effects of smoking. Psychopharmacology (Berl) 2006, 184:600-607.
37. Tonstad S, Johnston JA: Does bupropion have advantages over other medical therapies in the cessation of smoking? Expert Opin Pharmacother 2004, 5:727-734.
38. Gourlay SG, Stead LF, Benowitz NL: Clonidine for smoking cessation. Cochrane Database Syst Rev 2004, (3):CD000058.
39. Tonstad S: Rimonabant: a cannabinoid receptor blocker for the treatment of metabolic and cardiovascular risk factors. Nutr Metab Cardiovasc Dis 2006, 16:156-162.
40. Ludvig J, Miner B, Eisenberg MJ: Smoking cessation in patients with coronary artery disease. Am Heart J 2005, 149:565-572.
41. Hjermann I, Holme I, Leren P: Oslo Study Diet and Antismoking Trial. Results after 102 months. Am J Med 1986, 80(suppl 2A):7-11.
42. Vlietstra RE, Kronmal RA, Oberman A, et al.: Effect of cigarette smoking on survival of patients with angiographically documented coronary artery disease: report from the CASS registry. JAMA 1986, 255:1023-1027.